Search Results for keywords:"confidentiality protocols"

Search Results: keywords:"confidentiality protocols"

S. 1097 — To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
April 10, 2025
Status:Reported to Senate
Congress:119
Words:2,071
The bill S. 1097 seeks to amend title 35 of the United States Code by establishing an interagency task force between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA). This task force is designed to enhance information sharing...
Simple Explanation
The bill wants to help two important groups, the USPTO and the FDA, work together better to share information about patents, especially for medicines, by making a special team to improve how they communicate and keep information safe.
S. 1097 — To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
March 24, 2025
Status:Introduced in Senate
Congress:119
Words:1,964
S. 1097 aims to create a special task force between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) to increase collaboration and information sharing related to patents for human drugs and biological products. It proposes...
Simple Explanation
S. 1097 wants to create a team to help two big groups, one that handles patents and one that checks new medicines, share information better so they can do their jobs faster and safer. The team will also secretly share useful tips and make a big report later to see how well they're doing.

Showing 1 to 2 of 2 results